| 17.01 -0.26 (-1.51%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.79 | 1-year : | 21.59 |
| Resists | First : | 17.8 | Second : | 18.48 |
| Pivot price | 17.19  |
|||
| Supports | First : | 16.7 | Second : | 13.89 |
| MAs | MA(5) : | 17.31 |
MA(20) : | 17.16 |
| MA(100) : | 17.07 |
MA(250) : | 16.65 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 44.6 |
D(3) : | 60.7 |
| RSI | RSI(14): 47.1 |
|||
| 52-week | High : | 18.75 | Low : | 15.26 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SWKH ] has closed above bottom band by 26.7%. Bollinger Bands are 40.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 17.04 - 17.12 | 17.12 - 17.19 |
| Low: | 16.67 - 16.76 | 16.76 - 16.84 |
| Close: | 16.88 - 17.02 | 17.02 - 17.14 |
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
Thu, 18 Apr 2024
SWKH or AXP: Which Is the Better Value Stock Right Now? - Yahoo Movies UK
Tue, 16 Apr 2024
SWK (NASDAQ:SWKH) Trading Up 0.8% - MarketBeat
Tue, 09 Apr 2024
SWK Holdings Offers Attractive 9% Baby Bond (NASDAQ:SWKH) - Seeking Alpha
Sat, 23 Mar 2024
SWK Holdings Corp (SWKH) Earnings: A Mixed Bag with Revenue Uptick and Net Income Dip - Yahoo Finance
Thu, 21 Mar 2024
SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2023 - Yahoo Finance
Thu, 21 Mar 2024
SWKH Stock Earnings: SWK Holdings Misses EPS, Beats Revenue for Q4 2023 - InvestorPlace
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 13 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 1.9 (%) |
| Held by Institutions | 93.4 (%) |
| Shares Short | 66 (K) |
| Shares Short P.Month | 57 (K) |
| EPS | 1.25 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 22.43 |
| Profit Margin | 46.7 % |
| Operating Margin | 38 % |
| Return on Assets (ttm) | 5 % |
| Return on Equity (ttm) | 5.6 % |
| Qtrly Rev. Growth | 2.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 2.72 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 3.2 % |
| Operating Cash Flow | 15 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 13.6 |
| PEG Ratio | 0.4 |
| Price to Book value | 0.75 |
| Price to Sales | 6.25 |
| Price to Cash Flow | 14.27 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|